Trip12, a HECT domain E3 ubiquitin ligase, targets Sox6 for proteasomal degradation and affects fiber type-specific gene expression in muscle cells

Skeletal Muscle

Volumn 3, Issue 1, 2013, Pages

  An, Chung Il ^a   Ganio, Edward ^a   Hagiwara, Nobuko ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

E3 ubiquitin ligase; Fiber type differentiation; HECT domain; Skeletal muscle; Sox6; Trip12; Ubiquitin proteasome system

Indexed keywords

EID: 84877309486     PISSN: None     EISSN: 20445040     Source Type: Journal    
DOI: 10.1186/2044-5040-3-11     Document Type: Article

References (58)

1. Baylor SM, Hollingworth S. Intracellular calcium movements during excitation-contraction coupling in mammalian slow-twitch and fast-twitch muscle fibers. J Gen Physiol 2012, 139:261-272. 10.1085/jgp.201210773, 3315149, 22450485.
2. Schiaffino S, Reggiani C. Fiber types in mammalian skeletal muscles. Physiol Rev 2011, 91:1447-1531. 10.1152/physrev.00031.2010, 22013216.
3. Zierath JR, Hawley JA. Skeletal muscle fiber type: influence on contractile and metabolic properties. PLoS Biol 2004, 2:e348. 10.1371/journal.pbio.0020348, 521732, 15486583.
4. Chemello F, Bean C, Cancellara P, Laveder P, Reggiani C, Lanfranchi G. Microgenomic analysis in skeletal muscle: expression signatures of individual fast and slow myofibers. PLoS One 2011, 6:e16807. 10.1371/journal.pone.0016807, 3043066, 21364935.
5. Seene T, Kaasik P, Umnova M. Structural rearrangements in contractile apparatus and resulting skeletal muscle remodelling: effect of exercise training. J Sports Med Phys Fitness 2009, 49:410-423.
6. Selsby JT, Morine KJ, Pendrak K, Barton ER, Sweeney HL. Rescue of dystrophic skeletal muscle by PGC-1alpha involves a fast to slow fiber type shift in the mdx mouse. PLoS One 2012, 7:e30063. 10.1371/journal.pone.0030063, 3256197, 22253880.
7. Webster C, Silberstein L, Hays AP, Blau HM. Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy. Cell 1988, 52:503-513. 10.1016/0092-8674(88)90463-1, 3342447.
8. Schakman O, Gilson H, Thissen JP. Mechanisms of glucocorticoid-induced myopathy. J Endocrinol 2008, 197:1-10. 10.1677/JOE-07-0606, 18372227.
9. An CI, Dong Y, Hagiwara N. Genome-wide mapping of Sox6 binding sites in skeletal muscle reveals both direct and indirect regulation of muscle terminal differentiation by Sox6. BMC Dev Biol 2011, 11:59. 10.1186/1471-213X-11-59, 3239296, 21985497.
10. Hagiwara N, Yeh M, Liu A. Sox6 is required for normal fiber type differentiation of fetal skeletal muscle in mice. Dev Dyn 2007, 236:2062-2076. 10.1002/dvdy.21223, 17584907.
11. Hagiwara N, Ma B, Ly A. Slow and fast fiber isoform gene expression is systematically altered in skeletal muscle of the Sox6 mutant, p100H. Dev Dyn 2005, 234:301-311. 10.1002/dvdy.20535, 16124007.
12. Quiat D, Voelker KA, Pei J, Grishin NV, Grange RW, Bassel-Duby R, Olson EN. Concerted regulation of myofiber-specific gene expression and muscle performance by the transcriptional repressor Sox6. Proc Natl Acad Sci USA 2011, 108:10196-10201. 10.1073/pnas.1107413108, 3121857, 21633012.
13. Varshavsky A. The ubiquitin system, an immense realm. Annu Rev Biochem 2012, 81:167-176. 10.1146/annurev-biochem-051910-094049, 22663079.
14. Geng F, Wenzel S, Tansey WP. Ubiquitin and proteasomes in transcription. Annu Rev Biochem 2012, 81:177-201. 10.1146/annurev-biochem-052110-120012, 3637986, 22404630.
15. Glass DJ. Signaling pathways perturbing muscle mass. Curr Opin Clin Nutr Metab Care 2010, 13:225-229. 10.1097/MCO.0b013e32833862df, 20397318.
16. Cohen-Barak O, Yi Z, Hagiwara N, Monzen K, Komuro I, Brilliant MH. Sox6 regulation of cardiac myocyte development. Nucleic Acids Res 2003, 31:5941-5948. 10.1093/nar/gkg807, 219484, 14530442.
17. Cohen-Barak O, Hagiwara N, Arlt MF, Horton JP, Brilliant MH. Cloning, characterization and chromosome mapping of the human SOX6 gene. Gene 2001, 265:157-164. 10.1016/S0378-1119(01)00346-8, 11255018.
18. Park Y, Yoon SK, Yoon JB. The HECT domain of TRIP12 ubiquitinates substrates of the ubiquitin fusion degradation pathway. J Biol Chem 2009, 284:1540-1549.
19. Niikura Y, Nonaka T, Imajoh-Ohmi S. Monitoring of caspase-8/FLICE processing and activation upon Fas stimulation with novel antibodies directed against a cleavage site for caspase-8 and its substrate, FLICE-like inhibitory protein (FLIP). J Biochem 2002, 132:53-62. 10.1093/oxfordjournals.jbchem.a003198, 12097160.
20. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002, 3:RESEARCH0034. 126239, 12184808.
21. Andersen CL, Jensen JL, Orntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 2004, 64:5245-5250. 10.1158/0008-5472.CAN-04-0496, 15289330.
22. Hagiwara N. Sox6, jack of all trades: a versatile regulatory protein in vertebrate development. Dev Dyn 2011, 240:1311-1321. 10.1002/dvdy.22639, 3092843, 21495113.
23. Iguchi H, Urashima Y, Inagaki Y, Ikeda Y, Okamura M, Tanaka T, Uchida A, Yamamoto TT, Kodama T, Sakai J. SOX6 suppresses cyclin D1 promoter activity by interacting with beta-catenin and histone deacetylase 1, and its down-regulation induces pancreatic beta-cell proliferation. J Biol Chem 2007, 282:19052-19061. 10.1074/jbc.M700460200, 17412698.
24. Kamachi Y, Uchikawa M, Kondoh H. Pairing SOX off: with partners in the regulation of embryonic development. Trends Genet 2000, 16:182-187. 10.1016/S0168-9525(99)01955-1, 10729834.
25. Lefebvre V, Li P, de Crombrugghe B. A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J 1998, 17:5718-5733. 10.1093/emboj/17.19.5718, 1170900, 9755172.
26. Ohe K, Tamai KT, Parvinen M, Sassone-Corsi P. DAX-1 and SOX6 molecular interplay results in an antagonistic effect in pre-mRNA splicing. Dev Dyn 2009, 238:1595-1604. 10.1002/dvdy.21957, 19384854.
27. Connor F, Wright E, Denny P, Koopman P, Ashworth A. The Sry-related HMG box-containing gene Sox6 is expressed in the adult testis and developing nervous system of the mouse. Nucleic Acids Res 1995, 23:3365-3372. 10.1093/nar/23.17.3365, 307212, 7567444.
28. Rotin D, Kumar S. Physiological functions of the HECT family of ubiquitin ligases. Nat Rev Mol Cell Biol 2009, 10:398-409. 10.1038/nrm2690, 19436320.
29. Lee JW, Choi HS, Gyuris J, Brent R, Moore DD. Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. Mol Endocrinol 1995, 9:243-254. 10.1210/me.9.2.243, 7776974.
30. Chen D, Shan J, Zhu WG, Qin J, Gu W. Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses. Nature 2010, 464:624-627. 10.1038/nature08820, 20208519.
31. Keppler BR, Archer TK. Ubiquitin-dependent and ubiquitin-independent control of subunit stoichiometry in the SWI/SNF complex. J Biol Chem 2010, 285:35665-35674. 10.1074/jbc.M110.173997, 2975191, 20829358.
32. Park Y, Yoon SK, Yoon JB. TRIP12 functions as an E3 ubiquitin ligase of APP-BP1. Biochem Biophys Res Commun 2008, 374:294-298. 10.1016/j.bbrc.2008.07.019, 18627766.
33. Kajiro M, Tsuchiya M, Kawabe Y, Furumai R, Iwasaki N, Hayashi Y, Katano M, Nakajima Y, Goto N, Watanabe T. The E3 ubiquitin ligase activity of Trip12 is essential for mouse embryogenesis. PLoS One 2011, 6:e25871. 10.1371/journal.pone.0025871, 3196520, 22028794.
34. Hagiwara N, Klewer SE, Samson RA, Erickson DT, Lyon MF, Brilliant MH. Sox6 is a candidate gene for p100H myopathy, heart block, and sudden neonatal death. Proc Natl Acad Sci USA 2000, 97:4180-4185. 10.1073/pnas.97.8.4180, 18189, 10760285.
35. Hoppe T. Multiubiquitylation by E4 enzymes: 'one size' doesn't fit all. Trends Biochem Sci 2005, 30:183-187. 10.1016/j.tibs.2005.02.004, 15817394.
36. Zhou P. Determining protein half-lives. Methods Mol Biol 2004, 284:67-77.
37. Boisvert FM, Ahmad Y, Gierlinski M, Charriere F, Lamont D, Scott M, Barton G, Lamond AI. A quantitative spatial proteomics analysis of proteome turnover in human cells. Mol Cell Proteomics 2012, 11:M111 011429. 3316722, 21937730.
38. Kisselev AF, Goldberg AL. Proteasome inhibitors: from research tools to drug candidates. Chem Biol 2001, 8:739-758. 10.1016/S1074-5521(01)00056-4, 11514224.
39. Vinals F, Ventura F. Myogenin protein stability is decreased by BMP-2 through a mechanism implicating Id1. J Biol Chem 2004, 279:45766-45772. 10.1074/jbc.M408059200, 15322112.
40. Silva JM, Li MZ, Chang K, Ge W, Golding MC, Rickles RJ, Siolas D, Hu G, Paddison PJ, Schlabach MR. Second-generation shRNA libraries covering the mouse and human genomes. Nat Genet 2005, 37:1281-1288.
41. Hughes SM, Chi MM, Lowry OH, Gundersen K. Myogenin induces a shift of enzyme activity from glycolytic to oxidative metabolism in muscles of transgenic mice. J Cell Biol 1999, 145:633-642. 10.1083/jcb.145.3.633, 2185087, 10225962.
42. Brown DM, Parr T, Brameld JM. Myosin heavy chain mRNA isoforms are expressed in two distinct cohorts during C2C12 myogenesis. J Muscle Res Cell Motil 2012, 32:383-390. 10.1007/s10974-011-9267-4, 22012579.
43. von Hofsten J, Elworthy S, Gilchrist MJ, Smith JC, Wardle FC, Ingham PW. Prdm1- and Sox6-mediated transcriptional repression specifies muscle fibre type in the zebrafish embryo. EMBO Rep 2008, 9:683-689. 10.1038/embor.2008.73, 2424280, 18535625.
44. Sluijter JP, van Mil A, van Vliet P, Metz CH, Liu J, Doevendans PA, Goumans MJ. MicroRNA-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells. Arterioscler Thromb Vasc Biol 2010, 30:859-868. 10.1161/ATVBAHA.109.197434, 20081117.
45. Komander D, Rape M. The ubiquitin code. Annu Rev Biochem 2012, 81:203-229. 10.1146/annurev-biochem-060310-170328, 22524316.
46. Scheffner M, Staub O. HECT E3s and human disease. BMC Biochem 2007, 1(8 Suppl):S6.
47. Gudjonsson T, Altmeyer M, Savic V, Toledo L, Dinant C, Grofte M, Bartkova J, Poulsen M, Oka Y, Bekker-Jensen S. TRIP12 and UBR5 suppress spreading of chromatin ubiquitylation at damaged chromosomes. Cell 2012, 150:697-709. 10.1016/j.cell.2012.06.039, 22884692.
48. Lindon C, Albagli O, Domeyne P, Montarras D, Pinset C. Constitutive instability of muscle regulatory factor Myf5 is distinct from its mitosis-specific disappearance, which requires a D-box-like motif overlapping the basic domain. Mol Cell Biol 2000, 20:8923-8932. 10.1128/MCB.20.23.8923-8932.2000, 86547, 11073992.
49. Sun L, Trausch-Azar JS, Muglia LJ, Schwartz AL. Glucocorticoids differentially regulate degradation of MyoD and Id1 by N-terminal ubiquitination to promote muscle protein catabolism. Proc Natl Acad Sci USA 2008, 105:3339-3344. 10.1073/pnas.0800165105, 2265166, 18296633.
50. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233. 10.1016/j.cell.2009.01.002, 19167326.
51. Bell ML, Buvoli M, Leinwand LA. Uncoupling of expression of an intronic microRNA and its myosin host gene by exon skipping. Mol Cell Biol 2010, 30:1937-1945. 10.1128/MCB.01370-09, 2849460, 20154144.
52. McCarthy JJ, Esser KA, Peterson CA, Dupont-Versteegden EE. Evidence of MyomiR network regulation of beta-myosin heavy chain gene expression during skeletal muscle atrophy. Physiol Genomics 2009, 39:219-226. 10.1152/physiolgenomics.00042.2009, 2789671, 19690046.
53. Rossi AC, Mammucari C, Argentini C, Reggiani C, Schiaffino S. Two novel/ancient myosins in mammalian skeletal muscles: MYH14/7b and MYH15 are expressed in extraocular muscles and muscle spindles. J Physiol 2010, 588:353-364. 10.1113/jphysiol.2009.181008, 2821527,2821527, 19948655.
54. van Rooij E, Quiat D, Johnson BA, Sutherland LB, Qi X, Richardson JA, Kelm RJ, Olson EN. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev Cell 2009, 17:662-673. 10.1016/j.devcel.2009.10.013, 2796371, 19922871.
55. Dugas JC, Cuellar TL, Scholze A, Ason B, Ibrahim A, Emery B, Zamanian JL, Foo LC, McManus MT, Barres BA. Dicer1 and miR-219 Are required for normal oligodendrocyte differentiation and myelination. Neuron 2010, 65:597-611. 10.1016/j.neuron.2010.01.027, 2843397, 20223197.
56. Zhao X, He X, Han X, Yu Y, Ye F, Chen Y, Hoang T, Xu X, Mi QS, Xin M. MicroRNA-mediated control of oligodendrocyte differentiation. Neuron 2010, 65:612-626. 10.1016/j.neuron.2010.02.018, 2855245, 20223198.
57. Fernandez-Lloris R, Osses N, Jaffray E, Shen LN, Vaughan OA, Girwood D, Bartrons R, Rosa JL, Hay RT, Ventura F. Repression of SOX6 transcriptional activity by SUMO modification. FEBS Lett 2006, 580:1215-1221. 10.1016/j.febslet.2006.01.031, 16442531.
58. Schiaffino S, Sandri M, Murgia M. Activity-dependent signaling pathways controlling muscle diversity and plasticity. Physiology (Bethesda) 2007, 22:269-278.